
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.46 | 0.57 | 0.11 |
Shares | 97.66 | 97.66 | 0.00 |
Other | 1.88 | 1.88 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.24 | 18.98 |
Price to Book | 4.09 | 4.25 |
Price to Sales | 6.35 | 2.32 |
Price to Cash Flow | 15.45 | 16.25 |
Dividend Yield | 1.36 | 1.16 |
5 Years Earnings Growth | 7.43 | 11.84 |
Number of long holdings: 90
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 19.28 | 191.08 | -0.70% | |
Gilead | US3755581036 | 9.00 | 109.98 | -1.15% | |
Regeneron Pharma | US75886F1075 | 6.58 | 529.32 | +1.43% | |
Alnylam | US02043Q1076 | 5.88 | 307.99 | +1.09% | |
Ascendis Pharma AS | US04351P1012 | 5.42 | 170.80 | -0.07% | |
Amgen | US0311621009 | 4.96 | 295.22 | -0.70% | |
argenx ADR | US04016X1019 | 4.63 | 577.62 | -1.56% | |
Nuvalent Inc Class A | - | 2.29 | - | - | |
Neurocrine | US64125C1099 | 2.16 | 124.39 | -0.50% | |
Xenon Pharmaceuticals | CA98420N1050 | 1.99 | 32.76 | -0.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 593.97B | 1.06 | 14.40 | 12.85 | ||
Fidelity Contrafund | 133.44B | 4.72 | 21.82 | 15.21 | ||
Fidelity Total Market Index Instl b | 99.37B | 0.53 | 13.74 | 12.15 | ||
Fidelity International Index Inst | 58.83B | 17.65 | 11.69 | 6.14 | ||
Fidelity Blue Chip Growth | 54.71B | -3.61 | 21.81 | 16.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review